Copyright: ©Author(s) 2026.
World J Clin Cases. Jun 16, 2026; 14(17): 121315
Published online Jun 16, 2026. doi: 10.12998/wjcc.v14.i17.121315
Published online Jun 16, 2026. doi: 10.12998/wjcc.v14.i17.121315
Table 1 Overview of the clinical characteristics and treatment outcomes of patients with colorectal cancer with seminal vesicle metastasis
| Ref. | Primary tumor location | Site of metastasis | Timing of metastasis | Metastasis therapy | Survival status |
| Arenas Hoyos et al[1] | Transverse colon | Left seminal vesicle | 6 years postoperatively | 6 cycles of FOLFIRI + panitumumab | Death at 3 months |
| Hsu et al[9] | Ascending colon | Right seminal vesicle | 3 years postoperatively | Metastasectomy + systemic therapy | NR |
| Atici et al[11] | Descending colon | Left seminal vesicle | 15 months postoperatively | Metastasectomy | NR |
| Current case | Rectosigmoid junction | Right seminal vesicle | Synchronous | Synchronous colon resection and metastasectomy + 12 cycles of mFOLFOX6 | NED at 2 years |
- Citation: Wang XP, Zheng YZ, Zhang YC. Synchronous seminal vesicle metastasis from rectosigmoid adenocarcinoma: A case report. World J Clin Cases 2026; 14(17): 121315
- URL: https://www.wjgnet.com/2307-8960/full/v14/i17/121315.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i17.121315